1. The Needs Improvement of Surgical Masks
A medical mask is designed to prevent infection by filtering bacteria, drops, and sol air from entering the user’s mouth and nose. However, with this design, there exist limitations that bring the risk of cross-contamination of infectious viruses on the surface of surgical masks. The question here is whether the mask can filter the virus? The current standard respirator includes the N95 standard and medical respirator that has been tested to filter 95% particles approximately 0.3 microns in diameter thanks to its electrostatic properties that trap dirt and dust, bacteria with a diameter of about 1 micron. Meanwhile, the size of the most interesting virus strain now is Coronavirus with a smaller size of about 0.05 – 0.2 micron .
On the other hand, experts warn users not to touch the mask’s surface and thus spread germs to other surfaces. Since the filtered pathogenic microorganisms trapped on the surface of the mask do not die, they are still alive and growing. According to research, Coronavirus can last up to 7 days on disposable surgical masks . To solve the above disadvantages, Medical masks WAKAMONO been studied and created not only filtering but also destroy viruses and bacteria.
2. The World’s First Medical/Surgical Mask Applied Nano Biotech to Stop Covid-19 Pandemic
WAKAMONO surgical mask is the world’s first Nano Biotech application mask to prevent the COVID-19 pandemic. To do that, thanks to GECIDE FABRIC layer – the inner layer of WAKAMONO Medical mask. With the Innovation Nano technology, the inner layer of WAKAMONO Medical Mask is covered with millions of organic nanoparticles which are selected from billions of molecules of natural origin that crystallize to form millions of “traps” that weaken and destroy “preys” are viruses and bacteria when they are touch these organic nanoparticles.
The World’s First Medical Mask Applied Nano Biotech has been shown to be effective against 99% of the strains of SARS-CoV-2 which is the Human Coronavirus strain causing the COVID-19 pandemic. This special mask is also capable of self-killing Coronavirus strains including strain NL63, 229E. Not only that, it also inactivated influenza A H1N1 – the enveloped viruses and Poliovirus-I – the non-enveloped viruses. It is evidence that it can destroy all variants of Human Coronavirus. Moreover, WAKAMONO Medical Mask kills 99.9% of pathogenic bacteria.
1ISO 18184:2019 – Guangdong Detection Center of Microbiology (China)
2ASTM E2315:2016 – Analytical Laboratories (Singapore) Pet Ltd.
3AATCC 100:2019 – Quality Assurance And Testing Center 3 (Vietnam)
4ISO 18184:2019 – J K Analytical Laboratory & Research Center (India)
According Guideline for Disinfection and Sterilization in Healthcare Facilities (2008) – CDC: Non-enveloped viruses are more resistant to changes in temperature, pH, and some disinfectants than are enveloped viruses . Coronavirus and its variants, are enveloped viruses, and for this reason they have the same sensitivity to disinfectants. If some of them produce more human pathology than others (like SARS-Cov-2), it is because they interact with host cell receptors differently.
3. WAKAMONO Surgical Mask – A Standard One
Besides the ability to antiviral, WAKAMONO surgical mask transcends the basic protection standards established for surgical/medical masks. WAKAMONO surgical mask meet and exceed the highest FDA standards of the US, which is ASTM F2100 level 3 and European CE EN 14683 Type IIR.
4. Wakamono Surgical Mask – Certified Biosafety
The surgical mask using Nano Biotechnology contains biocide organic and natural components. It is certificated safe (Biosafety) according to Tests for in vitro cytotoxicity ANSI/AAMI/ISO 10993-5:2009 by Pacific Labs (USA). WAKAMONO medical masks do not apply metal nanoparticles in masks.
Why does WAKAMONO not use nano-metal particles?
Due to these old technologies (nanosilver, nanocopper, nanotitanium, etc.) have the potential to affect human health that has been discussed by the European Commission about their safety, less friendly to the environment and user friendly . Examples of nanotechnology silver using compounds AgNPs, while having light AgNPs releasing silver ions (Ag+) in order to break the structure and loss of function of organs in cells lead to cell damage . According to the study, silver ions concentration increases to 100 µg/mL, the cell viability decreases to 74.5% .
In addition, another weakness, AgNPs are rapidly converted to more stable form in certain condition, which reduces the particles’ ability to release silver ions and kill bacteria .
WAKAMONO SURGICAL MASK – THE WORLD’S FIRST MASK TESTED EFFECTIVE AGAINST CORONAVIRUS 99% PROVEN
 Ijaz, M. K., Sattar, S. A., Rubino, J. R., Nims, R., & Gerba, C. P. (2020, April 17). Combating SARS-CoV-2: Leveraging microbicidal experiences with other emerging/re-emerging viruses.
 Chin, A. W. H., Chu, J. T. S., Perera, M. R. A., Hui, K. P. Y., Yen, H.-L., Chan, M. C. W., Poon, L. L. M. (2020). Stability of SARS-CoV-2 in different environmental conditions. The Lancet Microbe.
 William A. Rutala, Ph.D., M.P.H., David J. Weber, M.D., M.P.H., and the Healthcare Infection Control Practices Advisory Committee (HICPAC)
 Liao, C., Li, Y., & Tjong, S. C. (2019). Bactericidal and Cytotoxic Properties of Silver Nanoparticles. International journal of molecular sciences, 20(2), 449.
 Carrola, J., Bastos, V., Jarak, I., Oliveira-Silva, R., Malheiro, E., Daniel-da-Silva, A. L., Oliveira, H., Santos, C., Gil, A. M., & Duarte, I. F. (2016). Metabolomics of silver nanoparticles toxicity in HaCaT cells: structure-activity relationships and role of ionic silver and oxidative stress. Nanotoxicology, 10(8), 1105–1117.
 Seltenrich N. (2013). Nanosilver: weighing the risks and benefits. Environmental health perspectives, 121(7), A220–A225.
History of WAKAMONO CORPORATION
NANOBIOTECHNOLOGY LEADERS UNITE TO STAND WITH SCIENCE
WAKAMONO is a science-led nanobiotechnology company that focus on the discovery, development, manufacturer of nanomaterial primarily for medical devices, food, functional foods, cosmetic, … At WAKAMONO, we are blending our heart, science and ingenuity to create product to guide the future of people. Today, WAKAMONO is continuous to be at the forefront of research to prevent and protect diseases especially SARS-CoV-2 causing COVID-19 that threaten people and animals. By applying Nano Biotech, we aspire to be the premier research and manufacturer-intensive biotechnology company in the world.
MR. NAM HAI LAI
FOUNDER/INVENTOR/CEO – WAKAMONO Corporation
Tel & whatsapp: +84 977 88 88 69
Company Name: WAKAMONO corporation
Contact Person: Ngoc Dang
Email: Send Email
Phone: +84 938677781
Address:Saigon Hi-tech Park, District 9
City: Ho Chi Minh City
State: Ho Chi Minh City